IP Library › Patent Application 14493950
Patent Application
App. No. 14/493,950

DIAGNOSTIC REAGENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/493,950
Abstract

There is provided a diagnostic reagent useful to determine whether an animal has a tuberculosis infection or has been exposed to a tuberculosis agent, for example a Mycobacterium . The reagent is useful to distinguish between such an animal and an animal which has been vaccinated against a tuberculosis infection.

Claims (18)

1 . A diagnostic reagent comprising a polypeptide comprising ammo acid sequence SEQ ID NO:7 or a functional variant thereof, characterised in that the reagent elicits a negative diagnostic assay result when a tuberculosis infection assay is carried out on a sample from an animal which has been vaccinated against infection by a tuberculosis agent.

2 - 17 . (canceled)

18 . A method of detecting a tuberculosis infection in an animal, or exposure of an animal to a tuberculosis agent, comprising the steps of

(i) contacting a population of cells from the animal with at least one diagnostic reagent consisting of amino acid sequence SEQ ID NO:7, or consisting of a polypeptide having 20-65 amino acids and comprising SEQ ID NO:7, or comprising a polypeptide which is a functional variant of SEQ ID NO:7 having 2, 4, or 5 amino acids added to or deleted from the N- or C-terminus and/or having at least 85% sequence identity to SEQ ID NO:7, characterised in that the reagent elicits a negative diagnostic assay result when a tuberculosis infection assay is carried out on a sample from an animal which has been vaccinated against infection by a tuberculosis agent using the live attenuated M. bovis strain Bacille Calmette-Guerin (BCG); and

(ii) determining whether the cells of said population recognise the diagnostic reagent.

19 . The method according to claim 18 , wherein the population of cells includes T-cells.

20 . The method according to claim 18 , comprising a cell-mediated immunity 10 (CMI) assay.

21 . The method according to claim 20 , wherein the CMI assay detects interferon gamma (IFN-γ).

22 . A method of detecting a tuberculosis infection in an animal, or exposure of an animal to a tuberculosis agent, comprising conducting a skin test on the animal using at least one diagnostic reagent consisting of amino acid sequence SEQ ID NO:7, or consisting of a polypeptide having 20-65 amino acids and comprising SEQ ID NO:7, or comprising a polypeptide which is a functional variant of SEQ ID NO:7 having 2, 4, or 5 amino acids added to or deleted from the N- or C-terminus and/or having at least 85% sequence identity to SEQ ID NO:7, characterised in that the reagent elicits a negative diagnostic assay result when a tuberculosis infection assay is carried out on a sample from an animal which has been vaccinated against infection by a tuberculosis agent using the live attenuated M. bovis strain Bacille Calmette-Guerin (BCG).

23 - 27 . (canceled)

28 . A nucleic acid encoding a polypeptide comprising at least one polypeptide comprising the amino acid sequence of any of SEQ ID NOs:1-10 and/or 50-69 or a functional variant thereof.

29 - 30 . (canceled)

31 . The method of claim 18 , wherein said diagnostic reagent further comprises at least one of the amino acid sequences SEQ ID NO:1, 2, 3, 4, 5, 6 or 9 or functional variants thereof, or comprising all of SEQ ID NOs:1-9.

32 . The method of claim 18 , wherein said diagnostic reagent further comprises a polypeptide of the amino acid sequence of SEQ ID NO:10 or a functional variant thereof.

33 . The method of claim 18 , wherein said diagnostic reagent further comprises further comprising at least one of the amino acid sequences SEQ ID NOs:11-69 or functional variants thereof.

34 . The method of claim 22 , wherein said diagnostic reagent further comprises at least one of the amino acid sequences SEQ ID NO:1, 2, 3, 4, 5, 6 or 9 or functional variants thereof, or comprising all of SEQ ID NOs:1-9.

35 . The method of claim 22 , wherein said diagnostic reagent further comprises a polypeptide of the amino acid sequence of SEQ ID NO:10 or a functional variant thereof.

36 . The method of claim 22 , wherein said diagnostic reagent further comprises further comprising at least one of the amino acid sequences SEQ ID NOs:11-69 or functional variants thereof.

Assignments (2)
CHANGE OF ADDRESS Recorded Feb 2, 2016
From: JONES, GARETH; VORDERMEIR, HANS
To: THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS ACTING THROUGH THE ANIMAL AND PLANT HEALTH AGENCY
Reel/Frame 037642/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2014
From: JONES, GARETH; VORDERMEIER, HANS
To: THE SECRETARY OF STATE FOR ENVIRONMENT, FOOD AND RURAL AFFAIRS ACTING THROUGH THE ANIMAL HEALTH VETERINARY LABORATORIES AGENCY
Reel/Frame 033821/0510 →